About Us

Home  >  About Us  >  Scientific Advisory Board

Dr. Luc Vachon , Ph.D, President of the Advisory Board

Dr. Vachon has more than 25 years of experience in drug development. He has worked in two multinational pharmaceutical organizations, a CRO, and two “biotech” companies. He has held various positions, including Global Product Team Leader, Executive V.-P. of R&D, CEO and president, and has also been teaching in the academia. He is presently active as independent consultant in drug development.

Dr. Bélanger is a member of the pain clinic at the Hôtel-Dieu de Lévis and at Clinique Médicale Valcartier. He is a recognized medical expert in pain management and provides continuing education on pain management for multiple provincial and national programs.

Dr. Gordon D. Ko , MD, CCFP(EM), FCFP,  FRCPC

Dr. Ko is a specialist in Physical Medicine and Rehabilitation (Physiatry) with subspecialty in Pain Medicine. He is former Senior University Associate Professor and current Medical Director, Interventional Physiatry clinics and Adjunct Lecturer at Sunnybrook Health Sciences Centre, University of Toronto and the Canadian Centre for Integrative Medicine (Markham). His expertise with Platelet-rich Plasma (PRP) for Back Pain and Botox injections for Osteoarthritis made headline CTV national news. With over 25 years experience in treating Fibromyalgia(FMS) and chronic neuropathic pain (including Cannabinoids, Functional Medicine), he was selected on the Canadian Pain Society committee that developed new guidelines (2012) for FMS management. More recently, he was lead author for a peer-reviewed review paper (J Pain Research 2016) on Medical Cannabis: a Canadian Perspective.

Dr. Pierre Arsenault , Ph.D., M.D., CPI

Dr. Arsenault is a family medicine practitioner and pain management expert and is an associate professor of family medicine at Université de Sherbrooke. He has a vast experience in clinical research and is a Clinical Physician Investigator (CPI) at DIEX Research.

Dr. Chamberland received a Bachelor of Law degree from the Université de Sherbrooke, a doctorate in medicine from the Université de Montréal, a diploma in psychiatry from the Université de Montréal, and a diploma of advanced studies in biological and medical ethics of the René Descartes University in Paris. In 2012, he earned the Distinguished Fellow from the Canadian Psychiatric Association and, by 2015 the American Psychiatric Association gave him the same professional recognition. He received a diploma in the subspecialty of Forensic Psychiatry in 2013 from the Royal College of Physicians and Surgeons of Canada. Dr. Chamberland has a vast experience in clinical management of patients suffering from various psychiatric conditions including marijuana induced-psychosis. He is also a well-known author and expert witness in the field on psychiatry.